First Trust Advisors
ARIA

First Trust Advisors’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

First Trust Advisors’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-165,020
Closed -$2.05M – 2553
2016
Q4 		$2.05M Buy
165,020
+28,085
+21% +$338K 0.01% 1434
2016
Q3 		$1.88M Buy
136,935
+71,827
+110% +$721K 0.01% 1366
2016
Q2 		$481K Buy
+65,108
New +$488K ﹤0.01% 1968

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

First Trust Advisors's ARIA Position: Q1 2017 in Review

First Trust Advisors sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 165,020 shares — an estimated $2.05M sold.

First Trust Advisors first reported a position in ARIA in Q2 2016 and held it in 3 quarters. The position peaked at $2.05M in Q4 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • First Trust Advisors reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • First Trust Advisors sold 165,020 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $2.05M.
  • First Trust Advisors first reported a position in Ariad Pharmaceuticals Inc in Q2 2016 and held it in 3 quarters.
  • First Trust Advisors's Ariad Pharmaceuticals Inc position peaked at $2.05M in Q4 2016.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on First Trust Advisors's 13F filing for Q1 2017, filed 2 May 2017.